Due to successful results in the first phase of our study on the effects of our Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project.
Testing our products to prove clinical efficacy is one of our core values, and something that sets us apart in the industry. Due to successful results in the first phase of our study on the effects of our Lycored Lutein Complex on ocular blood flow, we’re set to proceed with phase two of the project. The results of the study showed that subjects who ingested our blend had significantly reduced systolic and diastolic blood pressures and increased retinal capillary blood flow markers. Professor Alon Harris, principal clinical study investigator, believes that “these initial results of the […] study showcase the importance of the development of supplements for eyes and where the future of the vision health industry is heading.” We hope to keep the promising results coming, and we’re excited to see what phase two brings.
FDA Announces “No Artificial Colors” Label Update Earlier this month, the United States Food and Drug Administration (FDA) announced it will loosen regulations around the use of voluntary “No Artificial...
A New Year and Bright Road Ahead! Dear Partners, I’m beginning my first full year leading Lycored feeling inspired by the significant milestones of 2025: Our 30-year anniversary. We celebrated...
Two of our powerhouse beauty from within solutions — both derived from tomatoes —made the European Food Safety Authority (EFSA) list of novel foods and are officially available for sale...
Interested in speaking directly with a member of our team?
Click below to get in touch.